Drug firm Zenotech Laboratories has received market regulator Sebi's approval to raise up to Rs 120 crore through an issue of shares to its existing shareholders. DNA, 2 weeks ago
Zenotech Laboratories gets Sebi#39;s go-ahead for rights issue - Money Control, 2 weeks ago
1 images for "zenotech"
Realty firm Mahindra Lifespace Developers has received capital markets regulator Sebi's approval to raise up to Rs 300 crore through rights issue. In a rights issue, shares are issued to existing shareholders as per their holding at a pre-determined price and ...Business Standard, 1 month ago 4 cos file papers to raise about Rs 700 cr via rights issue Business Standard, 1 month ago
on your WebpageAdd Widget >Get your members hooked!